Viewing StudyNCT00083616



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00083616
Status: COMPLETED
Last Update Posted: 2014-01-10
First Post: 2004-05-26

Brief Title: Evaluating Panitumumab ABX-EGF Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine Irinotecan and Oxaliplatin Chemotherapy
Sponsor: Amgen
Organization: Amgen

Organization Data

Organization: Amgen
Class: INDUSTRY
Study ID: 20030167
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Amgen
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators